Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
11.70
-1.60 (-12.03%)
At close: Mar 9, 2026, 4:00 PM EDT
11.98
+0.28 (2.39%)
After-hours: Mar 9, 2026, 7:02 PM EDT
Trevi Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,500 | 368 | 86 | 116 | 20 | 44 | |
| Market Cap Growth | 249.75% | 330.28% | -26.01% | 472.04% | -54.55% | -33.49% | |
| Enterprise Value | 1,306 | 304 | -2 | 1 | 6 | 5 | |
| Last Close Price | 11.70 | 4.12 | 1.34 | 1.93 | 0.78 | 2.42 | |
| PB Ratio | 7.90 | 3.70 | 1.04 | 1.08 | 1.18 | 1.63 | |
| P/TBV Ratio | 7.91 | 3.70 | 1.04 | 1.08 | 1.18 | 1.63 | |
| Debt / Equity Ratio | 0.00 | 0.01 | 0.02 | 0.09 | 0.86 | 0.52 | |
| Net Debt / Equity Ratio | -1.02 | -1.07 | -0.99 | -1.04 | -1.29 | -1.13 | |
| Net Debt / EBITDA Ratio | 3.79 | 2.08 | 2.42 | 3.73 | 0.68 | 0.95 | |
| Net Debt / FCF Ratio | 4.41 | 2.78 | 2.56 | 3.93 | 0.76 | 1.06 | |
| Quick Ratio | 21.69 | 10.29 | 14.33 | 8.99 | 2.90 | 8.10 | |
| Current Ratio | 21.93 | 10.41 | 15.03 | 9.15 | 2.98 | 8.33 | |
| Return on Equity (ROE) | -36.87% | -52.59% | -30.59% | -46.82% | -153.03% | -80.07% | |
| Return on Assets (ROA) | -23.93% | -32.15% | -19.96% | -23.15% | -47.42% | -37.91% | |
| Return on Capital Employed (ROCE) | -27.00% | -51.30% | -40.60% | -27.30% | -126.10% | -78.10% | |
| Earnings Yield | -3.06% | -13.01% | -33.97% | -25.21% | -167.88% | -73.64% | |
| FCF Yield | -2.93% | -10.40% | -37.22% | -24.50% | -143.18% | -65.27% | |
| Buyback Yield / Dilution | -24.43% | -2.97% | -53.44% | -182.56% | -26.48% | -53.88% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.